PPAR{alpha} attenuates the proinflammatory response in activated mesangial cells

Area of Science:

• Nephrology
• Immunology
• Cell Biology

Background:

• Activated mesangial cells are key targets for treating glomerulonephritis.
• The anti-inflammatory role of peroxisome proliferator-activated receptor alpha (PPARalpha) is known, but its function in mesangial cells is unclear.

Purpose of the Study:

• To investigate the anti-inflammatory function of PPARalpha in mesangial cells.
• To explore the therapeutic potential of PPARalpha in glomerular diseases.

Main Methods:

• Cultured wild-type and Ppara-null mesangial cells were treated with lipopolysaccharide (LPS).
• Proinflammatory responses, cell proliferation, and the nuclear factor (NF)-kappaB pathway were assessed.
• PPARalpha expression and activation were examined in LPS-injected wild-type mice.

Main Results:

• LPS induced greater inflammation in Ppara-null cells than wild-type cells, evidenced by increased interleukin-6 and NF-kappaB activation.
• LPS treatment induced PPARalpha expression and activation in wild-type mesangial cells, which counteracted inflammatory responses.
• PPARalpha induction correlated with alpha-smooth muscle actin expression, suggesting mesangial cell phenotypic changes.
• PPARalpha-positive cells were observed in glomeruli of LPS-injected mice, indicating in vivo relevance.

Conclusions:

• PPARalpha plays a critical role in reducing inflammation in activated mesangial cells.
• PPARalpha activation attenuates inflammatory responses by antagonizing the NF-kappaB signaling pathway.
• PPARalpha represents a potential therapeutic target for managing glomerular diseases.